ReviewCureus2025
Management of the Infrapatellar Fat Pad in Total Knee Arthroplasty: A Comprehensive Review of Recent Evidence.
Review in Cureus, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
2 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Surgical management of the infrapatellar fat pad (IPFP) during total knee arthroplasty remains debated: excision may improve exposure but risks tendon changes and pain, while preservation protects soft tissues yet limits visualisation. This review synthesises randomised trials and meta-analyses (2020-2025) comparing IPFP excision versus preservation. Outcomes, including anterior knee pain, functional scores such as Knee Society Score (KSS) and the Knee Injury and Osteoarthritis Outcome Score-Quality of Life subscale (KOOS-QoL), range of motion (ROM), patellar tendon length, and Insall-Salvati ratio (ISR), were evaluated at less than or equal to three months and 6-12 months. Evidence shows modest tendon shortening after excision without lasting differences in pain, function, or mobility. Preservation may offer small early recovery benefits, but long-term outcomes are equivalent. Intraoperative decisions should balance exposure needs with potential early advantages of preservation.
Indexed as
Identifiers
What Socratic holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.